Yiqi Du

5.1k total citations · 3 hit papers
98 papers, 3.1k citations indexed

About

Yiqi Du is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Yiqi Du has authored 98 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Surgery, 39 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Yiqi Du's work include Pancreatic and Hepatic Oncology Research (32 papers), Pancreatitis Pathology and Treatment (29 papers) and Helicobacter pylori-related gastroenterology studies (27 papers). Yiqi Du is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Pancreatitis Pathology and Treatment (29 papers) and Helicobacter pylori-related gastroenterology studies (27 papers). Yiqi Du collaborates with scholars based in China, United States and United Kingdom. Yiqi Du's co-authors include Xiangyu Kong, Zhaoshen Li, Qiwen Ben, Jun Gao, Zhao‐Shen Li, Yan-fang Gong, Zhendong Jin, Zhaoshen Li, Zhaoshen Li and Kaixuan Wang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Yiqi Du

94 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention

2023 86 citations Huiyun Zhu, Xiangyu Kong et al. profile →
An antibiotic-free platform for eliminating persistent Helicobacter pylori infection without disrupting gut microbiota

2024 60 citations Yongkang Lai, Xiaojing Yin et al. profile →
Biomaterials mediated 3R (remove-remodel-repair) strategy: holistic management of Helicobacter pylori infection

2025 19 citations Yiqi Du et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yiqi Du China	28	1.3k	1.2k	1.1k	948	629	98	3.1k
Ruihua Shi China	33	1.7k 1.3×	1.0k 0.9×	1.2k 1.1×	709 0.7×	1.2k 1.9×	160	3.8k
Benjamin C.Y. Wong Hong Kong	29	844 0.7×	988 0.8×	1.0k 0.9×	375 0.4×	574 0.9×	58	2.7k
Zhiping Yang China	33	1.2k 1.0×	573 0.5×	1.4k 1.2×	764 0.8×	416 0.7×	64	3.7k
Yasushi Toh Japan	38	1.6k 1.3×	1.2k 1.0×	1.8k 1.7×	357 0.4×	1.6k 2.6×	125	4.5k
Keisuke Miyake Japan	31	623 0.5×	1.5k 1.3×	1.6k 1.5×	495 0.5×	353 0.6×	82	3.1k
Andrés Redondo Spain	28	494 0.4×	1.0k 0.8×	895 0.8×	550 0.6×	548 0.9×	199	3.3k
Bin Sun China	31	299 0.2×	707 0.6×	1.1k 1.0×	729 0.8×	418 0.7×	94	3.0k
László Herszényi Hungary	23	600 0.5×	514 0.4×	467 0.4×	465 0.5×	295 0.5×	91	2.0k
Xianrui Wu China	25	474 0.4×	713 0.6×	1.3k 1.2×	805 0.8×	241 0.4×	93	2.6k

Countries citing papers authored by Yiqi Du

Since Specialization

Citations

This map shows the geographic impact of Yiqi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqi Du more than expected).

Fields of papers citing papers by Yiqi Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqi Du. The network helps show where Yiqi Du may publish in the future.

Co-authorship network of co-authors of Yiqi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqi Du. A scholar is included among the top collaborators of Yiqi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqi Du. Yiqi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Qian‐Li, Zhenyu Zhang, Xing Li, et al.. (2024). Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial. Chinese Medical Journal. 138(19). 2464–2471. 2 indexed citations

Ma, Aixia, et al.. (2024). An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model. Helicobacter. 29(4). e13123–e13123. 2 indexed citations

Hu, Yi, et al.. (2024). Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study. Helicobacter. 29(4). e13116–e13116. 3 indexed citations

Li, Zhaoshen, et al.. (2023). Alterations and clinical relevance of gut microbiota in patients with Peutz–Jeghers syndrome: A prospective study. Journal of Digestive Diseases. 24(3). 203–212. 4 indexed citations

Lai, Yongkang, et al.. (2023). Survival Outcome of Gastric Signet Ring Cell Carcinoma Based on the Optimal Number of Examined Lymph Nodes: A Nomogram- and Machine-Learning-Based Approach. Journal of Clinical Medicine. 12(3). 1160–1160. 2 indexed citations

Wang, Peng, et al.. (2020). Outcomes and safety of double-balloon enteroscopy in small bowel diseases: a single-center experience of 1531 procedures. Surgical Endoscopy. 35(2). 576–583. 19 indexed citations

Shi, Min, Heguo Yu, Ling Xu, et al.. (2019). Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway. Mediators of Inflammation. 2019. 1–11. 13 indexed citations

Wu, Hongyu, et al.. (2019). Clinical value of biochemical markers in predicting organ failure in acute pancreatitis induced by hyperlipidemia. 19(4). 252–255.

Li, Zhaoshen, Dong Wang, Fanyang Kong, et al.. (2019). A prospective comparison of conventional cytology and digital image analysis for the identification of pancreatic malignancy in patients undergoing EUS-FNA. Endoscopic Ultrasound. 8(4). 269–269. 6 indexed citations

10.

Du, Yiqi, Yan Chen, Huiyun Zhu, Zhendong Jin, & Zhaoshen Li. (2018). An unusual complication of cardia occlusion with lumen-apposing metal stent therapy for pancreatic pseudocyst. Endoscopic Ultrasound. 7(1). 61–61. 4 indexed citations

11.

Kong, Fanyang, Xuan Deng, Xiangyu Kong, et al.. (2018). ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF. Oncogene. 37(45). 5982–5996. 81 indexed citations

12.

Kong, Fanyang, Xiangyu Kong, Yiqi Du, et al.. (2017). STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α. Cancer Research. 77(24). 6851–6862. 32 indexed citations

13.

Zhang, Yao, et al.. (2017). Epidemiology of obscure gastrointestinal bleeding in China: A single‐center series and comprehensive analysis of literature. Journal of Digestive Diseases. 19(1). 33–39. 5 indexed citations

14.

Huang, Haitao, et al.. (2017). A reduced lymphocyte ratio as an early marker for predicting acute pancreatitis. Scientific Reports. 7(1). 44087–44087. 15 indexed citations

15.

Du, Yiqi, et al.. (2014). A single-center study of clinical re-evaluation of the new classification of acute pancreatitis. 14(1). 8–11. 2 indexed citations

16.

Li, Lei, Yiqi Du, Xiangyu Kong, et al.. (2013). Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer. Clinical Cancer Research. 19(17). 4651–4661. 85 indexed citations

17.

Du, Yiqi, Minghao Liu, Jun Gao, & Zhao‐Shen Li. (2013). Aberrant MicroRNAs Expression Patterns in Pancreatic Cancer and Their Clinical Translation. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 361–369. 22 indexed citations

18.

Xiao, Bin, Zhendong Jin, Zhaoshen Li, et al.. (2011). Intra-tumoral injection of E1B gene-deleted adenovirus combined with gemcitabine for unresectable pancreatic carcinoma: 19 cases analysis. 11(3). 163–166. 1 indexed citations

19.

Wang, Xiaowei, Jun Gao, Yan Ren, et al.. (2011). Detection of KRAS Gene Mutations in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for Improving Pancreatic Cancer Diagnosis. The American Journal of Gastroenterology. 106(12). 2104–2111. 34 indexed citations

20.

Jeremy, Anthony H.T., Yiqi Du, Michael F. Dixon, Philip A. Robinson, & Jean E. Crabtree. (2005). Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes and Infection. 8(2). 340–346. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact